Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.25 AUD | +8.70% | +47.06% | +42.86% |
May. 29 | Study Finds Cleo Diagnostics ' Blood Test Outperforms Clinical Benchmarks | MT |
Apr. 11 | Cleo Diagnostics Taps Lindus Health to Manage US Ovarian Cancer Clinical Trials | MT |
- Stock Market
- Equities
- COV Stock
- News Cleo Diagnostics Ltd
- MarketScreener Strategies